BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21451785)

  • 21. Physician knowledge and awareness of CA-125 as a screen for ovarian cancer in the asymptomatic, average-risk population.
    Stewart SL; Rim SH; Gelb CA
    Health Educ Behav; 2012 Feb; 39(1):57-66. PubMed ID: 21680807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henderson JT; Webber EM; Sawaya GF
    JAMA; 2018 Feb; 319(6):595-606. PubMed ID: 29450530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Problems and contradictions in the screening of ovarian cancer].
    Bucchi L
    Epidemiol Prev; 1995 Dec; 19(65):304-9. PubMed ID: 8852079
    [No Abstract]   [Full Text] [Related]  

  • 26. Early Detection of Ovarian Cancer.
    Elias KM; Guo J; Bast RC
    Hematol Oncol Clin North Am; 2018 Dec; 32(6):903-914. PubMed ID: 30390764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study.
    Robinson KM; Christensen KB; Ottesen B; Krasnik A
    Qual Life Res; 2012 Nov; 21(9):1519-25. PubMed ID: 22138966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian cancer: screening and future directions.
    Gupta KK; Gupta VK; Naumann RW
    Int J Gynecol Cancer; 2019 Jan; 29(1):195-200. PubMed ID: 30640704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the early detection of ovarian cancer: How to hear the whispers early.
    Cesario S
    Nurs Womens Health; 2010 Jun; 14(3):222-34. PubMed ID: 20579298
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian cancer screening: could you recommend it? No.
    Gérvas J
    Evid Based Med; 2016 Aug; 21(4):134-5. PubMed ID: 27302954
    [No Abstract]   [Full Text] [Related]  

  • 32. Expanding the public health research agenda for ovarian cancer.
    Trivers KF; Stewart SL; Peipins L; Rim SH; White MC
    J Womens Health (Larchmt); 2009 Sep; 18(9):1299-305. PubMed ID: 19702475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence.
    Harris R; Yeatts J; Kinsinger L
    Prev Med; 2011 Sep; 53(3):108-14. PubMed ID: 21820465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for early detection of ovarian cancer.
    Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
    Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer in Lynch syndrome; a systematic review.
    Helder-Woolderink JM; Blok EA; Vasen HF; Hollema H; Mourits MJ; De Bock GH
    Eur J Cancer; 2016 Mar; 55():65-73. PubMed ID: 26773421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evidence base for breast cancer screening.
    Glasziou P; Houssami N
    Prev Med; 2011 Sep; 53(3):100-2. PubMed ID: 21658406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family physicians' perspectives on ovarian cancer.
    Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D
    Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The next steps in improving the outcomes of advanced ovarian cancer.
    Openshaw MR; Fotopoulou C; Blagden S; Gabra H
    Womens Health (Lond); 2015 Jun; 11(3):355-67. PubMed ID: 26102473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
    Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No need for routine ovarian cancer screening.
    Harv Womens Health Watch; 2012 Dec; 20(4):1, 8. PubMed ID: 23342667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.